Rifamycin Sv Application To Subcutanous Tissue for Prevention of Post-Cesarean Surgical Site Infection

dc.authorscopusid 24461545200
dc.authorscopusid 24461500400
dc.authorscopusid 57217448856
dc.authorscopusid 6701754699
dc.contributor.author Köşüş, A.
dc.contributor.author Köşüş, N.
dc.contributor.author Güler, A.
dc.contributor.author Çapar, M.
dc.date.accessioned 2025-05-10T17:06:58Z
dc.date.available 2025-05-10T17:06:58Z
dc.date.issued 2010
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Köşüş A., Fatih University, Faculty of Medicine, Department of Obstetrics and Jynecology, Ankara, Turkey; Köşüş N., Fatih University, Faculty of Medicine, Department of Obstetrics and Jynecology, Ankara, Turkey; Güler A., Yüzüncü Yil University, Faculty of Medicine, Department of Obstetrics and Jynecology, Van, Turkey; Çapar M., Selçuk University, Meram Medical Faculty, Department of Obstetrics and Jynecology, Turkey en_US
dc.description.abstract Aim: The aim of this study was to compare the effect of Rifamycin SV application to subcutaneous tissue for prevention of post-caesarean wound infection with a traditional method used for preoperative antisepsis of skin; povidone-iodine and also to calculate cost of the treatment. Method: In this randomized prospective study, 1272 women were divided into two groups. Povidone-iodine was used for preoperative antisepsis and after closure of the skin in the first group. In the second group povidone-iodine was used in the same way but also subcutaneous tissue was irrigated with Rifamycin SV before closure of subcutaneous tissue. Result: Surgical site infection (SSI) was developed in 12 of 600 patients in the first group. All of them were superficial incisional SSI. In 2 cases wound was opened up to fascia. The overall rate of wound infection with pus was 2%. Total cost of 12 patients with SSI was $5386.In the 2nd group, SSI wasn't develop in any of the 596 patients. Total cost of the rifamycin SV used for washing of subcutaneous tissue was $876.12. Conclusion: Rifamycin SV application to subcutaneous tissue during cesarian effectively prevents SSI. It decreases both cost and morbidity caused by wound infection. en_US
dc.identifier.doi 10.29333/ejgm/82867
dc.identifier.endpage 276 en_US
dc.identifier.issn 1304-3889
dc.identifier.issue 3 en_US
dc.identifier.scopus 2-s2.0-79551666868
dc.identifier.scopusquality N/A
dc.identifier.startpage 269 en_US
dc.identifier.uri https://doi.org/10.29333/ejgm/82867
dc.identifier.uri https://hdl.handle.net/20.500.14720/6609
dc.identifier.volume 7 en_US
dc.identifier.wosquality N/A
dc.language.iso tr en_US
dc.publisher TIP ARASTIRMALARI DERNEGI en_US
dc.relation.ispartof European Journal of General Medicine en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Cesarian Section en_US
dc.subject Povidone-Iodine en_US
dc.subject Rifamycin en_US
dc.subject Surgical Site Infection en_US
dc.title Rifamycin Sv Application To Subcutanous Tissue for Prevention of Post-Cesarean Surgical Site Infection en_US
dc.type Article en_US
dspace.entity.type Publication

Files